A new resource is now available to download for free.

MASLD drug development is limited by models that don’t reflect human liver biology.

HUB’s patient-derived liver organoids retain donor genetics, architecture and physiology.

Download the Factsheet to learn:

• How organoids recapitulate steatosis and fibrosis
• Which readouts support target validation and screening
• Why donor diversity improves translation

Download your copy now.